EVMN
Evommune, Inc. · Healthcare
Chief Financial Officer Kyle Carver sold $415K of Evommune, Inc.
Sold$415,117
$22.84Price
18,175Shares
−23%Stake
What EVMN did after the filing
- The stock from Tue, Jun 2 open, $21.90
- −46.5%
- S&P 500, same days
- −0.8%
Measured over 30 trading days, to the Jul 16 close.
Traded Thu, May 28. Filed Mon, Jun 1, 7:59 PM ET, after the close. Returns use the Jun 2 open and the Jul 16 close. Not investment advice.